Tyrosinemia Type 1

DBCOND0091509Congenital, Hereditary, and Neonatal Diseases and AbnormalitiesNervous System Diseases

Tyrosinemia Type 1 is the indication for 1 drug in DrugBank. It is covered by 1 curated, structured indication.

Also known as
Tyrosinemia, Type I · Tyrosinemia I · Hereditary Tyrosinemia, Type I · Tyrosinemia type I · hereditary tyrosinemia type 1
Classified under
Indicated drugs

Resolves to

Vocabularies
MeSHM0328654SNOMED CT124536006MedDRA10063443UMLSC0268486

What you can answer from here — as of October 28, 2026

1Indicated drugWith each drug's targets and mechanism
Listed above
1Structured indicationPopulation, line of therapy, route and combination as fields, not prose
Sign in
10Clinical trialsPhase, status and sponsor resolved per trial
Sign in
1Drug reporting it as an adverse effectWith incidence where the label states it
Sign in

Which approved drugs for Tyrosinemia Type 1 share a target, and which companies have late-stage candidates against it?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In